TWD 22.75
(-19.04%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.2 Million TWD | -44.51% |
2022 | 2.17 Million TWD | 149.66% |
2021 | 872 Thousand TWD | 0.0% |
2020 | - TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 1.67 Million TWD | 243.85% |
2023 Q4 | 488 Thousand TWD | -32.22% |
2023 Q2 | 720 Thousand TWD | -36.0% |
2023 FY | 1.2 Million TWD | -44.51% |
2022 FY | 2.17 Million TWD | 149.66% |
2022 Q4 | 1.12 Million TWD | 0.0% |
2021 FY | 872 Thousand TWD | 0.0% |
2020 FY | - TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -65.934% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 99.892% |
Level Biotechnology Inc. | 660.61 Million TWD | 99.817% |
Sagittarius Life Science Corp | 440.46 Million TWD | 99.726% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 98.134% |
TaiMed Biologics Inc. | 491.77 Million TWD | 99.754% |
GlycoNex Incorporation | 2.54 Million TWD | 52.478% |
VBI | 55.85 Million TWD | 97.837% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 99.464% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 99.618% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | 94.019% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 99.695% |
Visgeneer Inc. | 147.99 Million TWD | 99.184% |
Mycenax Biotech Inc. | 652.62 Million TWD | 99.815% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 99.928% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 99.334% |
Neith Corporation | 39.9 Million TWD | 96.973% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 99.69% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 94.688% |
Enimmune corporation | 43.49 Million TWD | 97.223% |
TaiRx, Inc. | 5.08 Million TWD | 76.23% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 99.882% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 99.544% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 99.718% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 98.901% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 99.331% |
Lukas Biomedical Inc. | 231.83 Million TWD | 99.479% |
RBC Bioscience Corporation | 172.46 Million TWD | 99.3% |
BiOptic Inc. | 228.26 Million TWD | 99.471% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -1242.222% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | 87.316% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | 75.093% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 99.934% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | 94.627% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 99.144% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -50.062% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 99.849% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 97.878% |
AP Biosciences Inc | 32.25 Million TWD | 96.255% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 99.896% |
3D Global Biotech Inc. | 20.63 Million TWD | 94.145% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.616% |
Intech Biopharm Corporation | 25.84 Million TWD | 95.326% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 98.608% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 99.841% |
TCI GENE Inc. | 333.85 Million TWD | 99.638% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -6611.111% |
Senhwa Biosciences, Inc. | 1 Million TWD | -20.8% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 98.587% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 99.246% |
PharmaEngine, Inc. | 767.66 Million TWD | 99.843% |
Savior Lifetec Corporation | 1.05 Billion TWD | 99.885% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 99.019% |
OBI Pharma, Inc. | 41.54 Million TWD | 97.093% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 99.485% |
Acepodia, Inc. | 16.59 Million TWD | 92.72% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 96.897% |